CSIMarket
 


Reliv International Inc  (RELV)
Other Ticker:  
 

Reliv International Inc's Total Debt to Equity

RELV's quarterly Total Debt to Equity and Total Debt, Equity growth


In Spite of the debt repayement of 0%, in III Quarter 2020 ,Total Debt to Equity deteriorated to 0.08, below the Reliv International Inc's average Total Debt to Equity.

Within Major Pharmaceutical Preparations industry in the third quarter 2020, 69 other companies have achieved lower Total Debt to Equity than Reliv International Inc in the III Quarter 2020. While Total Debt to Equity total ranking has deteriorated compared to the second quarter 2020 from 390 to 516 .

Explain Debt to Equity Ratio?
What is the structure of RELVīs Total Debt?
How valuable is the RELVīs Equity?


RELV Total Debt to Equity (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity Change -1.01 % -1.93 % -3.35 % -7.43 % -5.39 %
Y / Y Total Debt Change 72.4 % 72.4 % 0 % - -
Total Debt to Equity MRQ 0.08 0.07 0.04 0.05 0.04
RELV's Total Ranking # 516 # 390 # 209 # 209 # 227
Seq. Equity Change -0.67 % -1.82 % 5.61 % -3.88 % -1.6 %
Seq. Total Debt Change 0 % 72.4 % 0 % 0 % 0 %



Total Debt to Equity third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 70
Healthcare Sector # 114
Overall Market # 516


Total Debt to Equity Statistics
High Average Low
0.29 0.18 0.04
(Dec 31 2011)   (Mar 31 2019)




Financial Statements
Reliv International Inc's Equity $ 11 Millions Visit RELV's Balance sheet
Reliv International Inc's Total Debt $ 1 Millions Visit RELV's Balance sheet
Source of RELV's Sales Visit RELV's Sales by Geography


Cumulative Reliv International Inc's Total Debt to Equity

RELV's Total Debt to Equity for the trailling 12 Months

RELV Total Debt to Equity

(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity TTM Growth -1.01 % -1.93 % -3.35 % -7.43 % -5.39 %
Y / Y Total Debt TTM Growth 72.4 % 72.4 % 0 % - -
Total Debt to Equity TTM 0.06 0.05 0.04 0.04 0.03
Total Ranking TTM # 560 # 996 # 814 # 1033 # 13
Seq. Equity TTM Growth -0.67 % -1.82 % 5.61 % -3.88 % -1.6 %
Seq. Total Debt TTM Growth 0 % 72.4 % 0 % 0 % 0 %


On the trailing twelve months basis Despite of the debt repayement of 0% in the trailing twelve months ending in III Quarter 2020, Total Debt to Equity improved to 0.06, below Reliv International Inc's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 80, during the past 12 months, other companies have achieved lower Total Debt to Equity than Reliv International Inc. While Total Debt to Equity total ranking has improved so far to 560, from total ranking in previous 12 month period at 996.

Explain Debt to Equity Ratio?
What is the structure of RELVīs Total Debt?
How valuable is the RELVīs Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 135
Within the Market # 560


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.25 0.12 0.02
(Jun 30 2016)   (Jun 30 2019)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2020, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2020 MRQ Total DebtSep 30 2020 MRQ Equity
Eagle Pharmaceuticals inc   0.20 $ 35.017  Millions$ 172.787  Millions
Otonomy Inc   0.20 $ 15.114  Millions$ 75.125  Millions
Regeneron Pharmaceuticals Inc   0.20 $ 1,978.300  Millions$ 10,125.500  Millions
Veru Inc   0.19 $ 5.842  Millions$ 30.111  Millions
Rocket Pharmaceuticals Inc   0.19 $ 46.897  Millions$ 241.841  Millions
Dmk Pharmaceuticals Corporation  0.19 $ 5.284  Millions$ 27.395  Millions
Harrow Inc   0.18 $ 4.579  Millions$ 24.928  Millions
Liquidia Corporation  0.18 $ 11.690  Millions$ 65.281  Millions
Molecular Templates inc   0.18 $ 14.822  Millions$ 84.441  Millions
Tg Therapeutics Inc   0.17 $ 29.664  Millions$ 170.658  Millions
Global Blood Therapeutics Inc.  0.16 $ 73.880  Millions$ 457.655  Millions
Uniqure N v   0.16 $ 35.494  Millions$ 227.893  Millions
Syndax Pharmaceuticals Inc   0.15 $ 20.006  Millions$ 131.977  Millions
Aytu Biopharma Inc   0.15 $ 13.749  Millions$ 91.063  Millions
Cv Sciences Inc   0.15 $ 2.906  Millions$ 19.449  Millions
Alpine Immune Sciences Inc   0.15 $ 10.059  Millions$ 67.468  Millions
Chemocentryx Inc.  0.15 $ 58.762  Millions$ 404.819  Millions
Opko Health Inc   0.14 $ 231.896  Millions$ 1,623.770  Millions
Enveric Biosciences Inc   0.14 $ 1.877  Millions$ 13.176  Millions
Elite Pharmaceuticals Inc   0.13 $ 1.945  Millions$ 14.617  Millions
Seres Therapeutics Inc   0.13 $ 24.977  Millions$ 188.052  Millions
Bicycle Therapeutics Plc  0.13 $ 14.427  Millions$ 109.551  Millions
Novan Inc   0.13 $ 0.956  Millions$ 7.453  Millions
Zosano Pharma Corporation  0.13 $ 7.064  Millions$ 55.244  Millions
Equillium Inc   0.13 $ 9.876  Millions$ 78.126  Millions
Orgenesis Inc   0.13 $ 10.896  Millions$ 86.808  Millions
Clearside Biomedical Inc   0.12 $ 0.991  Millions$ 8.124  Millions
Capricor Therapeutics inc   0.12 $ 3.694  Millions$ 30.408  Millions
Cti Biopharma Corp   0.12 $ 5.658  Millions$ 46.819  Millions
Sonoma Pharmaceuticals Inc   0.12 $ 1.359  Millions$ 11.562  Millions

Date modified: 2023-03-22T19:14:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Đ 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com